PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas.
Saved in:
| Title: | PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas. |
|---|---|
| Authors: | Daniel Y; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Rauch C; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Moutaux L; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Desquilles L; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Le Charpentier T; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Fekir K; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France.; Division of Trauma and Orthopaedic Surgery, University of Cambridge, Addenbrooke's Hospital, Hills road, Cambridge, UK., Cano L; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Catheline D; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Pierre S; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Burel A; Univ Rennes, CNRS, Inserm, MRIC-TEM platform, Rennes, France., Savary C; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Ribault C; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Bendavid C; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France.; CHU Rennes, Pontchaillou site, Rennes, France., Clément B; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Aninat C; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Rioux V; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Musso O; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Fromenty B; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France., Cabillic F; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France. florian.cabillic@univ-rennes.fr.; CHU Rennes, Pontchaillou site, Rennes, France. florian.cabillic@univ-rennes.fr., Corlu A; Inserm, Univ Rennes, INRAE, NuMeCan Institute, (Nutrition, metabolisms and cancer), Rennes, France. anne.corlu@inserm.fr. |
| Source: | Cell death & disease [Cell Death Dis] 2025 Nov 17; Vol. 16 (1), pp. 831. Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-4889 |
|---|---|
| DOI: | 10.1038/s41419-025-07799-3 |
